See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review claims
Explore by Goal
"If you thought that science was certain - well, that is just an error on your part."
- Richard Feynman
Low confidence. Please provide more context.
Quick Explanation
Copied
Yaowang Li — scientific strength review (evidence-limited)
Based only on the bibliometric snippet you provided (3 works listed + citation metrics such as total citations and h-index), Yaowang Li’s *measured* scientific footprint appears modest (very low h-index and low work count), and the listed topics look more clinical/engineering than molecular/bioinformatics. However, without DOIs/full-text study details for each work, I can’t credibly assess experimental rigor, reproducibility, or biological mechanistic contribution.
Long Explanation
BGPT Author Review — Yaowang Li
Date context: 2026-04-24
Epistemic status: This review is intentionally conservative because the prompt provides only a bibliometric snapshot and 3 paper titles—no DOIs, no abstracts/full text, and no study-level methods/outcomes. That prevents a high-fidelity scientific critique (e.g., sample size, controls, blinding, effect sizes, statistical validity, or biological mechanism).
1) What we can measure from your provided metrics
Total works (from your snippet): 3 listed works.
Total citations (from your snippet): 16.
h-index (from your snippet): 1.
Critical interpretation: A low h-index and low citation count can reflect many possibilities (career stage, field size, indexing completeness, venue visibility, coauthorship position, and publication age). Without full bibliographic records (DOIs/years/journals) and study-level content, citation metrics alone cannot validate scientific quality.
2) Works listed in your prompt (titles only)
Paper (title)
Paper ID (from prompt)
Study on the Application Effect of Clinical Nursing Path after Stanford B-type Endovascular Repair of Aortic Dissection
13fe60668c7466a0dfda506cd1cc7a972a190481
Optimization dispatch strategy considering renewable energy consumptive benefits based on “ source-load-energy storage ” coordination in power system
5bb9ad5abf6833a00f15f702e7f53e4b1aafde5d
GW25-e0615 Value of C-reactive protein in predicting adverse prognosis after cardiac valve replacement surgery in patient with Chronic Rheumatic Valve Disease
1cf63bbc905e9176aa4dcdcccc91ee82123e3bec
Bio/biomedical relevance check (skeptical): These titles suggest (i) clinical pathway evaluation in cardiovascular surgery settings, (ii) power-systems optimization (not bio), and (iii) biomarker prognostication (CRP) after valve replacement. None of the provided titles explicitly indicate molecular/cell-level biology, bioinformatics, or mechanistic experimental design.
3) Visual: citation-mass distribution (from provided totals)
Since only aggregate citations/h-index are provided (not per-paper citation counts), this visualization is a minimal “known vs unknown” panel.
4) Scientific strength critique (what I can and cannot conclude)
Known from prompt:
Bibliometrics appear limited (3 works, total citations 16, h-index 1).
Listed titles are dominated by clinical and one engineering/power-systems topic.
Not known (therefore not judged):
Study design quality (randomization, controls, blinding, inclusion/exclusion criteria).
Sample size and event counts, statistical plan, correction for multiple testing.
Effect sizes, uncertainty intervals, and whether findings replicate.
Data availability (datasets/analysis code), and whether analyses were pre-registered.
Citation counts can be influenced by venue prestige, community size, and indexing—not just scientific rigor.
Clinical biomarker studies (e.g., CRP prognostication) can be especially sensitive to confounding and selection bias, which cannot be assessed from titles.
Non-bioengineering work (power-systems optimization) does not directly inform biological mechanistic expertise.
5) What would most improve a true scientific strength assessment
Provide (for each paper): DOI (or full citation), year, journal/conference, study type (RCT/cohort/cross-sectional/modeling), sample size and key outcomes, and any available supplementary methods/data/code.
Then I can evaluate: appropriateness of statistical methods, risk of bias, reproducibility, generalizability, and whether the biological claims (if any) are mechanistically plausible.
6) Visual: prompt-bounded evidence map
A simple graph separating “metrics available” vs “mechanistic evidence missing”.
Feedback:
Updated: April 24, 2026
BGPT Author Review
Scientific Quality
20%
Based on provided evidence only: very low work count (3), very low h-index (1), and low total citations (16). Titles suggest limited direct biological/mechanistic scope (mostly clinical prognosis/pathway and one engineering topic). No DOIs/full text/methods are provided, so scientific rigor, reproducibility, and biological insight cannot be assessed; hence a low confidence but not zero score.
Communication Quality
30%
No writing quality can be judged because no abstracts, full texts, or presentation materials are provided—only titles. Title-level signals suggest biomedical/clinical and engineering claims, but clarity, structure, and argumentation quality remain unknown.
Author Novelty
20%
With only titles and no content, novelty cannot be evaluated. The clinical/prognostic framing and biomarker prediction phrasing appear likely to be incremental within typical clinical literature; engineering optimization title could be novel depending on specifics, which are not provided.
Scientific Rigor
20%
Rigor cannot be verified without study design details (controls, confounding handling, statistical methods, validation). Given that none of these are provided and the citation/h-index signals are low, a cautious low rigor assessment is warranted.
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
“The low citation count implies low scientific truthfulness.” (Not necessarily: citations reflect visibility/indexing and field size; need per-paper metrics and content to avoid citation-bias.)
“Title diversity implies lack of expertise.” (Not necessarily: interdisciplinary authorship is common; need author background and publication histories.)
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)
Quick Explanation
Long Explanation
Hypothesis Graveyard
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight